CAS: 1416153-62-2
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | SR 9238 REF: IN-DA01ENKVCAS: 1416153-62-2 | 98% | To inquire | Tue 17 Dec 24 |
 | SR9238 REF: TM-T16930CAS: 1416153-62-2 | 99.19% - 99.99% | 48.00 €~387.00 € | Fri 27 Dec 24 |
 | SR 9238 REF: TR-S684520CAS: 1416153-62-2 | - - - | 2,174.00 € | Mon 27 Jan 25 |
 | SR9238 REF: 3D-RGC15362CAS: 1416153-62-2 | Min. 95% | To inquire | Tue 28 Jan 25 |
Ref: IN-DA01ENKV
| 10mg | 151.00 € | ||
| 25mg | 164.00 € | ||
| 50mg | 276.00 € | ||
| 100mg | 623.00 € | ||
| 250mg | To inquire |
Estimated delivery in United States, on Tuesday 17 Dec 2024
SR9238
CAS:1416153-62-2
SR9238 is a synthetic agonist of liver X receptor inverse (IC50s: 214 nM and 43 …
Formula:
C31H33NO7S2
Purity:
99.19% - 99.99%
Color and Shape:
Solid
Molecular weight:
595.73
Ref: TM-T16930
| 2mg | 48.00 € | ||
| 5mg | 72.00 € | ||
| 10mg | 113.00 € | ||
| 25mg | 220.00 € | ||
| 50mg | 387.00 € |
Estimated delivery in United States, on Friday 27 Dec 2024
SR 9238
Controlled ProductCAS:1416153-62-2
Formula:
C31H33NO7S2
Color and Shape:
Neat
Molecular weight:
595.726
Ref: TR-S684520
| 250mg | 2,174.00 € |
Estimated delivery in United States, on Monday 27 Jan 2025
SR9238
CAS:1416153-62-2
SR9238 is a drug that is being developed for the treatment of hepatic steatosis, which …
Formula:
C31H33NO7S2
Purity:
Min. 95%
Molecular weight:
595.73 g/mol
Ref: 3D-RGC15362
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 28 Jan 2025
